Impact Of Red Complex Bacteria And TNF-α Levels On The Diabetic And Renal Status Of Chronic Kidney Disease Patients in The Presence And Absence Of Periodontitis

Dec 28, 2023

Simple Summary: Periodontitis, referred to as gum disease, is a serious bacterial infection that damages the surrounding structures of the teeth, including the bones, resulting in tooth loss without prompt treatment. The disease primarily occurs as a result of improper maintenance of the oral cavity, eventually causing gum infections, and teeth that are filled with food, tartar, and bacterial deposits. These harmful bacteria under the influence of various environmental and genetic risk factors may migrate to the blood vessels and reach various other organs, including the kidneys, thereby triggering the infection and resulting in the progression of systemic diseases. In this study, we focused on identifying the levels of gum-disease-causing bacteria and their byproducts, namely, TNF alpha in patients with or without chronic kidney disease. The study comprised 120 participants categorized into 4 groups on the basis of patients who had gum disease and a kidney disorder. Gum, renal, and diabetic parameters were recorded. The bacteria and their products were assessed and found to be higher in patients having both gum disease and CKD disorder. This study indicates that patients with severe gum disease and poor oral health are at risk of developing kidney problems. Thus, the early prevention of gum ailments might reduce the risk of future kidney diseases. 

36

cistanche order

Supportive Service Of Wecistanche-The largest cistanche exporter in the China:

Email:wallence.suen@wecistanche.com 

Whatsapp/Tel:+86 15292862950


Shop For More Specifications Details:

https://www.xjcistanche.com/cistanche-shop

CLICK HERE TO GET NATURAL ORGANIC CISTANCHE EXTRACT WITH 25% ECHINACOSIDE AND 9% ACTEOSIDE FOR KIDNEY INFECTION


Abstract: Scientific evidence shows a positive association in the etiopathogenesis of periodontitis and chronic kidney disease (CKD). Various confounding factors, such as obesity, diabetes, and inflammation, also play a significant role in the progression of CKD, which remains unexplored. We hypothesize the role of red complex bacteria with various confounding factors associated with chronic kidney disease. The study comprised a total of 120 participants categorized into 4 groups: the control group (C), periodontitis subjects without CKD (P), periodontally healthy chronic kidney disease subjects (CKD), and subjects having both periodontitis and CKD (P + CKD), with 30 subjects in each group. 


Demographic variables and periodontal, renal, and diabetic parameters were recorded. Tumor necrosis factor (TNF)-α levels and those of red complex bacteria such as Prophyromonas gingivalis (P.g), Treponema denticola (T.d), and Tonerella forsythia (T.f) were assessed, and the obtained results were statistically analyzed. Among the various demographic variables, age showed a level of significance. Mean PI, GI, CAL, and PPD (the proportion of sites with PPD ≥ 5 mm and CAL ≥ 3 mm) were elevated in the P + CKD group. Diabetic parameters such as fasting blood sugar (FBS) and HbA1c levels were also greater in the P + CKD group. Renal parameters such as eGFR and serum creatinine levels were greater in CKD patients. The estimation of red complex periodontal pathogens such as Pg, Td and Tf levels were significantly greater in the P and P + CKD groups. Pearson correlation analysis revealed a significant correlation of red complex bacteria with all variables. Greater levels of P.g, T.d and T.f were found in the P groups, thus indicating their important role in the initiation and progression of inflammation of periodontitis and CKD, with diabetes as one of the confounding factors. The study also confirmed a log-linear relationship between TNF-α levels and red complex bacteria, thereby demonstrating the role of inflammatory biomarkers in periodontal disease progression that could contribute to the development of systemic inflammation such as CKD. 


1. Introduction 

Chronic kidney disease (CKD) affects the quality of life of affected individuals. It can easily progress to advanced stages, thereby leading to greater morbidity and mortality rates. CKD is more prevalent in Asian populations in comparison with other ethnic groups. [1]. The disease affects 8% to 13% of the total global population [2]. The principal etiology of mortality in individuals suffering from CKD is the severity of the condition with increased inflammation that leads to cardiac complications [3].

CISTANCHE EXTRACT WITH 25% ECHINACOSIDE AND 9% ACTEOSIDE FOR KIDNEY

Periodontitis, on the other hand, is an inflammatory condition caused by Gram-negative bacteria associated with both local and systemic immune responses that lead to the destruction of the periodontium [4]. Periodontal disease results from a plethora of mechanisms associated with the cross-link between host factors and microbes [5,6]. Periodontitis on progression leads to intense local synthesis of proinflammatory cytokines that can enter the bloodstream, thereby resulting in elevated levels of inflammatory biomarkers in both gingival tissue and serum [7,8]. Thus periodontal disease is a major infectious scaffold that could potentiate systemic inflammatory levels, increasing patient morbidity [9]. In order to promptly diagnose and treat periodontal diseases, their classification is mandatory to both help in organizing healthcare to patients and assists scientists and researchers in understanding the aetiopathogenesis and treatment of such diseases in a sequential meticulous pattern. There are various classification systems proposed for the categorization of these periodontal diseases, of which the newly accepted 2017 AAP classification of periodontal and peri-implant diseases is applicable on categorizing the disease on both the basis of its severity and of the presence or absence of risk factors and complexity [5]. 

Periodontitis is a common and alterable risk factor for CKD, where it is hypothesized to cause renal impairment through an inflammatory pathway [10]. Inflammation stimulates the invasion of periodontal microorganisms in the host tissue and directly or indirectly enters the circulatory system [11]. An increased number of inflammatory mediators alter renal parameters, which in turn affects renal functions, thereby leading to the progression of chronic kidney disease. Greater serum antibody levels to periodontal pathogens reflect their systemic dissemination, thereby resulting in their vascular and hepatic activation [12]. There are various studies that discuss the role of periodontitis in CKD, but its impact in the presence of various confounding factors in the progression of the disease still remains unexplored [13,14].


The present research was conducted to assess the role of demographic and periodontal parameters, TNF-α, and red complex bacteria such as P.g, T.d, and T.f in association with confounding factors such as GFR, serum creatinine, FBS, and HbA1c levels on chronic kidney disease individuals in the presence or absence of periodontitis. The first null hypothesis of the current study is that there are no significant differences when comparing the levels of TNF-α and red-complex bacteria in chronic periodontitis patients with or without chronic kidney disease. The second null hypothesis of this study is that there is no influence of diabetic status in these patients with periodontitis with or without chronic kidney disease.

CISTANCHE EXTRACT WITH 25% ECHINACOSIDE AND 9% ACTEOSIDE FOR KIDNEY

2. Materials and Methods 

2.1. Study Design 

A cross-sectional study was performed following STROBE guidelines to report observational studies. The sample size was calculated using G-Power software to be 120 subjects with a power of 95%. The current study was conducted between January 2019 and February 2020 in Thrissur, Kerala, India, where patients were enrolled from PSM College of Dental Science and Research, Thrissur, and Thrissur Dialysis Center, India. Among the 180 examined subjects, 30 volunteers had come for a master health check-up in the general hospital of PSM College of Dental Science and Research, Thrissur, were both periodontally and systemically healthy and were categorized as the control group (C). We enrolled 40 periodontitis patients without CKD from the PSM Dental College of Sciences, Kerala, India, of which 10 patients were excluded as they had other systemic conditions. Lastly, 30 patients were selected with glomerular filtration rate > 90 mL/min, determined in accordance with the classification of CKD_EPI 2009, and hence were grouped as the P group. We recruited 43 periodontally healthy patients, diagnosed with CKD (Stages 2–4) from Thrissur Dialysis Center, India. Among them, 13 were excluded for having other systemic conditions and adverse habits such as smoking. Hence, 30 patients were selected for the CKD group. We recruited 47 periodontitis subjects with CKD from Thrissur Dialysis Center, India, and 17 patients of were excluded as they did not consent to be part of the study, thereby leading to a total number of 30 patients in the CKD + P group (Figure 1). Following a detailed explanation of the research protocol to the study participants, we obtained informed consent prior to the study being conducted. The Institutional Ethical Review Board of PSM College of Dental Science and Research (Thrissur, India) approved the research proposal with protocol no. PSMDC/IEC/01/2015. All procedures were executed following the Declaration of Helsinki of 1975, as revised in 2013. The confidence intervals were calculated with retrieved records from the hospital, which were 95% and 80%, with a final sample of 120 individuals. 

Lastly, the study comprised four groups: C group: 30 systemically and periodontally healthy subjects; P group: 30 systemically healthy periodontitis subjects; CKD group: 30 periodontally healthy subjects with CKD; P + CKD group: 30 CKD patients with periodontitis. Inclusion criteria: (a) willingness to participate; (b) age range: 35–65 years; (c) individuals with at least 12 natural teeth in the oral cavity; (d) in the case of CKD and C groups, subjects with intact periodontal health were recruited; (f) in the case of the P and CKD + P groups, individuals with periodontitis in accordance to the American Academy of Periodontology and European Federation of Periodontology 2017 classification were recruited, where interdental CAL was detectable at >2 nonadjacent teeth with CAL ≥ 3 mm and probing pocket depth >3 mm present in >2 teeth [15].

Chronic kidney disease was divided into five stages in accordance with the classification in Kidney Disease: Improving Global Outcomes (KDIGO) 2009, where predialysis patients were recruited for the study on the basis of the determined glomerular filtration rate (eGFR). Participants with GFR greater than or equal to 90 mL/min/1.73 m2 accounted for the C group. The CKD group comprised individuals clinically diagnosed with renal failure with a GFR range from 89 to 15 mL/min, and in predialysis conservative management [16].

CISTANCHE EXTRACT WITH 25% ECHINACOSIDE AND 9% ACTEOSIDE FOR KIDNEY

Figure 1. Study flowchart. Exclusion criteria: (a) individuals who had undergone periodontal treatment within six months prior to the study; (b) subjects with smoking, tobacco, and alcohol habits; (c) subjects with other systemic diseases such as cardiovascular diseases, hypertension, sarcoidosis, tuberculosis, carcinoma, rheumatoid arthritis, and immunosuppressive conditions, and subjects with other inflammatory conditions; (g) individuals with eGFR < 15 mL/min/1.73 m2 (there was a chance that they would be so ill that they could not participate in the study or would have commenced dialysis). 


2.2. Sample Collection 

2.2.1. Blood Collection 

Venous blood samples were collected by venepuncture in the morning after a 12 h fasting period in 5 mL centrifuge tubes without anticoagulant. Collected samples were left to clot for 1 h at room temperature, and the serum was then centrifuged for a period of 20 min at 3000 rpm for a period of 10 min. Centrifuged sera were stored at −70 ◦C until analysis.


2.2.2. Subgingival Plaque Sample Collection

On the first visit of the patient, during initial clinical examination, samples of plaque from a subgingival area were collected using Gracey curettes (Hu-Friedy, Chicago, IL, USA) from the deepest periodontal sites of periodontitis subjects in the presence and absence of chronic kidney disease. Collected plaque samples were mixed with RNA later solution (Qiagen, Hilden, Germany) for the prevention of transcriptome degradation, and stored at −80 ◦C till further experimentation. Following subgingival plaque collection, patients were subjected to an oral prophylaxis procedure for the removal of local factors. 


2.3. Assessed Study Parameters 

2.3.1. Demographic Variables 

Demographic information collected from the hospital records of the patients was (1) age, (2) gender, (3) body mass index, and (4) socioeconomic status.


2.3.2. Periodontal Parameters 

One trained blinded investigator used a William periodontal probe to perform intraoral examination of the periodontium. Periodontal parameters were PI [17], GI [17] , PPD, and CAL. Recordings were noted to the closest mm. The severity of periodontitis was graded and staged. Periodontal diagnosis of the selected subjects was in accordance with the guidelines presented by the 2017 International Workshop for the Classification of Periodontal Diseases and Conditions of the American Academy of Periodontology and the European Federation of Periodontology [16]. 


2.3.3. Diabetic Assessment 

Diabetic parameters such as HbA1C levels and fasting blood sugar levels were recorded for all participants. 


2.3.4. Renal Parameters 

Serum creatinine values were determined using an automated method from the collected blood samples with a semiautomated biochemical analyser. Estimated glomerular filtration rate (eGFR) was calculated with the serum creatinine values using the CKD-EPI equation of 2009. 


2.3.5. Tumour Necrosis Factor-α 

The concentration of inflammatory biomarker TNF-α was analysed using the ELISA method through the analysis of the venous blood samples collected from subjects of all four groups. Human TNF alpha ELISA kit (ab181421) was used to determine the marker by adhering to the instructions provided by the manufacturer. Prior to analysis, standardisation was performed, and samples were maintained to room temperature. The concentration of TNF-α levels was measured in picograms per millimetre (pg/mL)

CISTANCHE EXTRACT WITH 25% ECHINACOSIDE AND 9% ACTEOSIDE FOR KIDNEY

2.4. Molecular Analysis 

RT-PCR Analysis Subgingival plaque samples collected from the subjects were subjected to RT-PCR for the detection and quantification of red complex bacteria (P.g, T.d and T.f). Genomic DNA was isolated from the samples by using a rapid DNA kit (QIAamp DNA Minikit (QIAGEN Inc., 9300 Germantown Road, Germantown, MD 20874, USA)) by adhering to the protocol provided by the manufacturer. These extracted DNA samples were quantified using a spectrophotometer, where further complementary DNA (c-DNA) synthesis and RT-PCR analysis were performed using the Stratagene MX3000P (Agilent Technologies, 5301 Stevens Creek Blvd., Santa Clara, CA, USA). The amplification of c-DNA samples was performed in triplicate to eliminate errors, adhering to the standard operating procedure provided by the Takara kit (TB Green TMP remix Ex Taq TMII PCR Kit; Takara Bio Inc., Shiga, Japan). 

Double-standard DNA binding dye SYBR Green I (KAPA SYBR FAST qPCR Kit) using species-specific primers was utilised in the detection of Prophyromoans gingivalis, Treponema denticola, and Tonerella forsythia, and reaction efficacy was optimised. Melt curve analysis was conducted in every sample for identification of contaminants, multiple amplicons, and nonspecific products.

PCR products were visualised with 2% agarose gel electrophoresis and 100 bp molecular marker DNA with ethidium bromide control. Gene quantity was calculated with the comparative cycle threshold unit (CT) method. CT was used for the expression of the number of red complex bacteria, and CT values were inversely proportional to bacterial counts. 


2.5. Statistical Analysis 

Statistical Package for Social Science (SPSS, (IBM Corporation, Chicago, IL, USA) software program version 17) for Microsoft Windows was used to statistically analyse the obtained data. Normal distribution of data was observed. Descriptive statistics were presented with the aid of numbers and percentages. Mean and standard deviation for every parameter (demographic, renal, and periodontal) was determined for every group, and the level of significance was determined. To observe significant differences among groups, ANOVA was used. Pearson correlation coefficient analysis was performed to correlate the red complex bacteria with all the other parameters. It was considered to be statistically significant if p value ≤ 0.05. 



You Might Also Like